AbstractThe National Marrow Donor Program's Be The Match Registry® facilitates the worldwide utilization of unrelated donor (URD) grafts for patients in need of a hematopoietic cell transplantation. In this study, we estimate the URD match rate for patients of White (WH), Hispanic (HIS), Asian/Pacific Islander (API), and African American/Black (AFA) race and ethnic groups. We chose 1344 URD at random as “pseudo-patients” (PP) to estimate the likelihood of finding an 8/8 or 10/10 high-resolution HLA-A,-B,-C,-DRB1 (and -DQB1) matched URD. Searches were conducted in the Be The Match Registry database for each PP at 2 time points: 2009 and 2012. URD who were a potential match for a PP by low/intermediate resolution were HLA typed by sequence-ba...
<p>*: Both national registries may be identical if donor and patient live in the same country. **: T...
AbstractHigh incidences of graft failure, graft-vs.-host disease (GVHD), and serious infections foll...
Hematopoietic stem cell transplantation (HSCT) is the therapy of choice in many hematological malign...
AbstractThe National Marrow Donor Program's Be The Match Registry® facilitates the worldwide utiliza...
AbstractThe impact of non-HLA patient factors on the match of the selected unrelated donor (URD) for...
permits unrestricted use, distribution, and reproduction in any medium, provided the original work i...
AbstractThe best unrelated donors (URD) for hematopoietic cell transplantation (HCT) are alleles mat...
Sickle cell disease (SCD) is the most common inherited hemoglobinopathy. Hematopoietic stem cell tra...
Sickle cell disease (SCD) is the most common inherited hemoglobinopathy. Hematopoietic stem cell tra...
PurposeUltrahigh resolution (UHR) HLA matching is reported to result in better outcomes following un...
Identification of an unrelated HLA allele-matched hematopoietic stem cell (HSC) donor is a costly an...
Improving haematopoietic cell transplantation outcomes by selection of an HLA-matched unrelated dono...
The chance of finding an unrelated bone marrow donor depends on the size of the donor registry, the ...
International audienceIn the absence of an HLA matched familial donor, a search for an unrelated don...
BACKGROUND From 2011 to 2014, a total of 71% of the 3834 patients with hematologic malignancies suc...
<p>*: Both national registries may be identical if donor and patient live in the same country. **: T...
AbstractHigh incidences of graft failure, graft-vs.-host disease (GVHD), and serious infections foll...
Hematopoietic stem cell transplantation (HSCT) is the therapy of choice in many hematological malign...
AbstractThe National Marrow Donor Program's Be The Match Registry® facilitates the worldwide utiliza...
AbstractThe impact of non-HLA patient factors on the match of the selected unrelated donor (URD) for...
permits unrestricted use, distribution, and reproduction in any medium, provided the original work i...
AbstractThe best unrelated donors (URD) for hematopoietic cell transplantation (HCT) are alleles mat...
Sickle cell disease (SCD) is the most common inherited hemoglobinopathy. Hematopoietic stem cell tra...
Sickle cell disease (SCD) is the most common inherited hemoglobinopathy. Hematopoietic stem cell tra...
PurposeUltrahigh resolution (UHR) HLA matching is reported to result in better outcomes following un...
Identification of an unrelated HLA allele-matched hematopoietic stem cell (HSC) donor is a costly an...
Improving haematopoietic cell transplantation outcomes by selection of an HLA-matched unrelated dono...
The chance of finding an unrelated bone marrow donor depends on the size of the donor registry, the ...
International audienceIn the absence of an HLA matched familial donor, a search for an unrelated don...
BACKGROUND From 2011 to 2014, a total of 71% of the 3834 patients with hematologic malignancies suc...
<p>*: Both national registries may be identical if donor and patient live in the same country. **: T...
AbstractHigh incidences of graft failure, graft-vs.-host disease (GVHD), and serious infections foll...
Hematopoietic stem cell transplantation (HSCT) is the therapy of choice in many hematological malign...